I've written about metabolic syndrome as a five-point diagnostic cluster and about the endothelial dysfunction that connects it to cardiovascular disease. This post is about something I've only gestured at so far: just how far the downstream consequences actually extend. A recent review pulled together the full comorbidity picture across every major organ system, and I think it's worth walking through directly, because the reach is genuinely broader than most patients — and most providers, in my experience — appreciate.

Cardiovascular system

This is the territory I've already covered in depth: hypertension, coronary artery disease, heart failure, atrial fibrillation, stroke, and venous thromboembolism. I won't re-tread that ground here beyond noting that it remains the most well-established and most dangerous category of downstream risk.

Respiratory system

Obstructive sleep apnea and obesity hypoventilation syndrome are both strongly linked to metabolic syndrome, largely through the mechanical and inflammatory effects of visceral and upper-airway fat. Sleep apnea in particular deserves more attention than it typically gets in general metabolic care — untreated, it creates its own cycle of poor sleep, elevated inflammation, and worsened insulin resistance, compounding the very metabolic dysfunction that contributed to it in the first place.

Endocrine system

Type 2 diabetes, dyslipidemia, and metabolic syndrome itself sit here, alongside something less commonly discussed: vitamin D deficiency, which shows up with notable frequency in patients with significant visceral adiposity.

Nervous system

Idiopathic intracranial hypertension — elevated pressure around the brain without an identifiable structural cause — is associated with obesity and metabolic dysfunction, though it's a less commonly discussed connection. Depression also belongs in this category; the relationship runs in both directions, with metabolic dysfunction contributing to depression risk and depression, in turn, making metabolic self-care more difficult.

Musculoskeletal system

Osteoarthritis is driven partly by mechanical loading on weight-bearing joints, but the relationship isn't purely mechanical — systemic inflammation associated with metabolic syndrome appears to accelerate joint degeneration independent of body weight alone, which is part of why osteoarthritis shows up even in non-weight-bearing joints at higher rates in patients with metabolic dysfunction.

Gastrointestinal tract

Fatty liver disease — which I've covered in a dedicated post given how significant it is on its own — belongs here, alongside gallstones and gastroesophageal reflux disease, both of which occur at meaningfully higher rates in patients with metabolic syndrome.

Urinary tract

Chronic kidney disease and urinary incontinence both show elevated rates in patients with metabolic syndrome, the former largely through the same vascular and inflammatory mechanisms affecting the heart and brain, applied to the kidney's own dense blood vessel network.

Reproductive system

This category is broader than most people expect: irregular menstrual cycles, ovulatory dysfunction and infertility, increased miscarriage risk, endometrial hyperplasia and malignancy risk, polycystic ovary syndrome, and sexual dysfunction all connect back to the same underlying insulin resistance and hormonal disruption I've described elsewhere on this site — including the leptin and adiponectin post, where I covered how adipose tissue signaling directly affects hormonal regulation.

Skin and infection risk

Metabolic syndrome is associated with delayed wound healing, increased risk of pressure sores, and skin changes including hirsutism and acanthosis nigricans — a darkened, thickened patch of skin that's often one of the more visible clinical signs of underlying insulin resistance. Separately, patients with metabolic syndrome show higher rates of bacterial infections, higher post-surgical infection rates, and increased mortality from infections including influenza and COVID-19 — a connection I think deserves more clinical attention than it typically receives, since it affects real, practical decisions around surgical risk and infection prevention.

Cancer risk

This is the category I want to handle with real care, because the public figures cited for this connection vary more than most people realize, and I'd rather explain that range honestly than repeat whichever number sounds most dramatic.

A large, widely cited study following over 900,000 U.S. adults age 50 and older found that excess weight could account for as much as 14% of cancer deaths in men and 20% in women in that population. More recent estimates using different methodology, applied to the general population rather than an older cohort specifically, put the figure meaningfully lower — closer to 5–11% of cancer cases and roughly 7% of cancer deaths overall. Both figures are legitimate; they're measuring somewhat different things, using different populations and different statistical approaches, which is a useful reminder that even well-established risk relationships can produce a real range of numbers depending on how the question is framed.

What's more consistent across the research is the list of cancer types involved. Obesity is linked to increased risk across at least a dozen cancer types, including esophageal adenocarcinoma, gastric cancer, colorectal cancer, hepatocellular carcinoma, cholangiocarcinoma, pancreatic cancer, endometrial carcinoma, ovarian cancer, breast cancer, renal cell carcinoma, and multiple myeloma. Recent tracking data has also shown obesity-associated cancer mortality rising substantially over the past two decades — more than tripling between 1999 and 2020 by one recent analysis — which suggests this isn't a static risk factor but one that's becoming more clinically significant over time, not less.

Why I wanted to lay all of this out at once

I don't think any single patient needs to carry the weight of this entire list in their head. What I do think matters is understanding that metabolic syndrome isn't a narrow diagnosis confined to blood pressure and cholesterol numbers — it's a systemic condition with genuine reach into nearly every organ system, some of it well-known, some of it — reproductive health, skin changes, infection risk, cancer — much less commonly discussed in general conversation about weight and metabolism.

This is, in a real sense, the underlying argument for comprehensive care that's run through this entire site: treating metabolic dysfunction seriously, early, and systemically isn't about vanity or a number on a scale. It's about the genuinely wide reach of what happens when it goes unaddressed.

Curious how metabolic syndrome might be affecting a part of your health you hadn't connected to it?

No spam. Occasional new posts and updates from The Center for Metabolic Health.

Medical disclaimer: This content is provided for general educational and informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any condition, and it does not create a physician-patient relationship. Every patient's medical history, health status, and treatment needs are different. Always consult your own physician or qualified healthcare provider before starting, stopping, or changing any medication or treatment, and before making any decisions based on information found here. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.